Kinesiotaping in Trauma

Acromioclavicular Joint Dislocation Clinical Trial

— KIT  

Official title:

Kinesiotaping in Trauma

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05976256
• Other study ID #: WO 21.210
• Status: Not yet recruiting
• Phase: N/A
• Start date: September 1, 2023
• Est. completion date: December 31, 2025

Study information

• Verified date: July 2023
• Source: Onze Lieve Vrouwe Gasthuis
• Contact: Mireille Bakker, MSc
• Phone: +310205999111
• Email: m.e.bakker2[@]olvg.nl
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Rationale: Patients with acute traumatic injury to the shoulder or chest wall in de Emergency Department (ED) usually have intense pain. The patient normally is treated with oral analgesics as standard care and in shoulder injury with a sling. Pain of the shoulder or chest wall increases with movement of the affected arm and chest. Kinesiotaping is offered regularly as an additional pain treatment, but there is no hard evidence about its effectiveness. A randomized pilot study in OLVG (Bakker 2022) showed the pain decreasing more when using kinesiotaping comparing to no tape. However, a placebo-effect could not be ruled out and the pilot data need confirmation in a large cohort of patients to study the effectiveness of additional treatment with kinesiotaping in terms of pain, comfort and patient satisfaction.

Description:

Objective: The primary aim of this study is to evaluate the effect of kinesiotaping on number of patients with clinically meaningful pain reduction after 1 week in patients with acute traumatic injury in shoulder or chest wall, compared to sham tape and no tape. The secondary aims are to assess the effect of kinesiotaping on pain reduction at 15 min, 3 weeks and 8 weeks, and the effects on the skin, use of oral analgesics, independence, activity pattern, progress of pain symptoms, comfort and patient satisfaction at 1, 3 and 8 weeks. Also the need of physiotherapy is one of the secondary aims.

Study design: Parallel randomized controlled trial with three arms

Study population: Patients of or over 18 years old with an acute single shoulder or chest wall injury (rib fracture, disruption of the acromioclavicular (AC) joint Tossy type 1 and 2, not or hardly dislocated fracture of clavicle or proximal humeral bone).

Intervention (if applicable): One group will receive treatment with kinesiotaping, another group receives sham taping (no elastic tape) and the third group receives no taping. This treatment is additional to the general treatment with oral analgesics and a sling (when shoulder injury).

Main study parameters/endpoints: The main study parameter is the proportion of patients who experienced a clinically meaningful reduction in pain score (≥2 points on NRS) at week 1 compared to T1. The kinesiotape group will be compared to the sham group and to the control group.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:

At 15 minutes after receiving kinesio tape, sham tape or no tape, 1 week, 3 weeks and 8 weeks after visiting the emergency department the pain of these patients is evaluated using NRS by the Brief Pain Inventory (BPI). The effect of use of oral analgesics (questionnaire), on the skin (questionnaire), on independence, activity pattern and progress of pain symptoms (Groningen Activity Restriction Scale (GARS)), comfort and patient satisfaction (Global Perceived Effect (GPE-DV)) is evaluated after 1, 3 and 8 weeks. Physiotherapy is elevated after 8 weeks. Due to the limited seriousness of the injury and the non-invasive nature of the interventions, any serious complication or adverse event is not expected. Benefits of participating this study could be pain reduction in the affected body part.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 387
• Est. completion date: December 31, 2025
• Est. primary completion date: March 31, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• =18 years

• Acute injury (occurred <24 hours ago)

• Single shoulder or chest wall injury, which includes one of the following injuries:

• rib fracture

• disruption of the AC-joint Tossy type 1 and 2

• not or hardly dislocated fracture of the clavicle

• Not or hardly dislocated fracture of the r proximal humeral fracture

Exclusion Criteria:

• • Patients younger than 18 years

• Incapacitated persons

• Refusal of participation

• Intubation indication

• Decrease of Consciousness

• Hemodynamic instability

• 3 or more rib fractures

• Rib fracture rib 1-3

• Indication for surgery

• Hospitalization required

• Presence of a haemo- or pneumothorax with chest drain indication

• Already known with allergy for adhesive tape

• Patients with very thin or loose skin on the applicable body part

• Skin infection/irritation or open wound on the applicable body part

• Patients who do not speak Dutch or English

Related Conditions & MeSH terms

• Acromioclavicular Joint Dislocation
• Fracture Clavicle
• Fracture, Proximal Humeral
• Fractures, Bone
• Shoulder Fractures

Intervention

Other:
• Kinesio taping
Kinesio tape is a thin, elastic tape that applies pressure to the skin (because of the elasticity of the tape), reducing pain by reducing nociceptive stimulation.
• sham tape (leukotape classic)
leuko tape classic is used in this study to explore the possible placebo effect of kinesiotape
• standard treatment
standard treatment is the treatment with oral analgesics and a sling (if shoulder injury)

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Onze Lieve Vrouwe Gasthuis	OLVG

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	clinical meaningful pain reduction for the different intervention arms	In an exploratory analysis, we would like to assess in a subgroup analysis if the number of patients with clinically meaningful pain reduction after 15 minutes, 1 week, 3 weeks and 8 weeks for the different intervention arms differs between patients with uncomplicated rib fracture, disruption of the AC-joint, clavicle fracture, and proximal humeral fracture (using the BPI-NRS)	15 min, 1 week, 3 weeks and 8 weels
Primary	number of patients with clinically meaningful pain reduction	To evaluate the effect of kinesiotaping on number of patients with clinically meaningful pain reduction (Brief Pain Inventory (BPI)) after 1 week in patients with acute traumatic injury in shoulder or chest wall, compared to sham tape and no tape (2 comparisons).	1 week
Secondary	number of patients with clinically meaningful pain reduction	the proportion of patients who experience a clinically meaningful reduction in pain score (=2 points on NRS by BPI). The kinesiotape group will be compared to the sham group and to the control group (2 comparisons).	after 15 minutes, 3 weeks and 8 weeks
Secondary	evaluating skin defects by questionnaire	To assess potential skin abnormalities resulting from kinesio taping, a questionnaire will be distributed among the participants. This questionnaire is designed based on the decubitus stages. Additionally, in case of skin abnormalities or rashes, participants will be requested to upload a photograph of the affected area for independent evaluation of the skin condition.	1 week, 3 weeks and 8 weeks
Secondary	evaluating use of oral analgesics by questionnaire	To evaluate the utilization of oral analgesics, a questionnaire is administered to the participants to ascertain the type of medication employed, as well as to quantify the frequency and dosage of its usage.	after 1 week, 3 weeks and 8 weeks
Secondary	evaluating independence, pattern of activity and course of pain complaints by Groningen Activity Restriction Scale (GARS)	To delineate the independence, pattern of activity, and course of pain complaints, we employ the Groningen Activity Restriction Scale (GARS).	after 1 week, 3 weeks and 8 weeks
Secondary	Evaluating comfort and patient satisfaction by Global Perceived Effect (GPE-DV)	To gauge comfort and patient satisfaction, the Global Perceived Effect (GPE-DV) is utilized as a measurement tool.	after 15 minutes, 1 week, 3 weeks and 8 weeks
Secondary	Evaluating the need of physiotherapy by questionnaire	To gain insight into whether patients avail or have availed themselves of physiotherapy, a questionnaire is dispatched after 8 weeks, encompassing queries regarding the utilization of physiotherapy during the treatment period, its frequency, and the nature of the treatment sought.	8 weeks